ARCHIVES

Panel to Hear Innovation Reports

This article is from The Cancer Letter archive.

Vol. 14 No. 35 | August 26, 1988

Download PDF Visit The Full Archive

Related Articles

Interferon Alpha-2B Effective For Malignant Melanoma

July 27, 2001

FDA Approves Gleevec For First Line Rx Of CML

January 31, 2003

Informatics: Gore Helps NCI Open CGAP Website

August 8, 1997

President Signs Interim Money Bill; NCI At $725 Million

July 4, 1975

ASCO Updates Guideline On Follow-Up Management

October 27, 2006

Fox Chase Symposium Tro Focus On Year 2000 Goals

August 21, 1987